Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz & Miller LLP Announces Investigation of Curaleaf Holdings, Inc., Granite Construction, Inc., Karyopharm Therapeutics, Inc., ProPetro Holdings Corp., SAExploration, Inc., Sunnova Energy International, Inc., and Surface Oncology, Inc.

GVA, PUMP, NOVA

NEW YORK, Sept. 17, 2019 /PRNewswire/ --

Curaleaf Holdings, Inc. (CURLF)

Lifshitz & Miller announces investigation into possible securities laws violation in connection with the FDA's warning letter to Curaleaf stating that several of CURLF's CBD products were "misbranded drugs" in violation of the Federal Food, Drug, and Cosmetic Act.

If you are a CURLF investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Granite Construction, Inc. (GVA)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with GVA's disclosure that second quarter 2019 financial results were negatively impacted by non-cash charges related to four civil joint venture projects.

If you are a GVA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Karyopharm Therapeutics, Inc.

Lifshitz & Miller announces investigation into possible securities laws violations in connection with Karyopharm false represented the safety and efficacy of selinexor, a pharmaceutical drug intended for the treatment of various types of cancer that Karyopharm was in the process of developing.

If you are a KPTI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ProPetro Holdings Corp. (PUMP)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with ProPetro's disclosure of delays in both its scheduled conference call and in the filing of its 10-Q.

If you are a PUMP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

SAExploration, Inc. (SAEX)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that SAExploration improperly did not classify ALASKA Seismic Ventures, LLC as a variable interest entity.

If you are a SAEX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Sunnova Energy International, Inc. (NOVA)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with Sunnova's reported net loss of $85.3 million for the six month period ended June 30, 2019, due to net losses on interest rate swaps.

If you are a NOVA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Surface Oncology, Inc. (SURF)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with SURF's stock price falling to less than 15% of its IPO price.

If you are a SURF investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.

© 2019 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

 

Cision View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-curaleaf-holdings-inc-granite-construction-inc-karyopharm-therapeutics-inc-propetro-holdings-corp-saexploration-inc-sunnova-energy-international-inc-and-surface-onc-300920179.html

SOURCE Lifshitz & Miller Law Firm



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today